Result of Placing
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR").
15 November 2024
Duke Capital Limited
("Duke Capital", "Duke" or the "Company")
Result of Placing
Further to its announcement made on 14 November 2024 regarding a proposed fundraising to raise a minimum of £15 million by way of a placing, subscription, retail offer and broker option (the "Fundraising"), the Company is pleased to announce that, following the closing of the accelerated bookbuild, it has conditionally raised gross proceeds of £17.2 million (before expenses) under the Placing and Subscription, at the Issue Price of 27.5 pence per share, comprising 56,836,367 Placing Shares and 5,709,089 Subscription Shares.
Cavendish and Canaccord are acting as agents for and on behalf of the Company in respect of the Placing.
Separately, the Company announced a Retail Offer to raise up to an additional £3 million through the BookBuild Platform and a Broker Option pursuant to which additional orders for New Shares may be placed with the Joint Brokers. The result of the Retail Offer, Broker Option and final amount raised pursuant to the Fundraising is expected to be announced by the Company on or around 22 November 2024.
Related party transactions
Certain of the Company's Directors (the "Subscribing Directors"), have subscribed for an aggregate of 2,909,089 New Shares in the Fundraising at the Issue Price, as follows:
Name | Number of New Shares conditionally acquired by relevant person |
Neil Johnson | 363,636 |
Nigel Birrell | 363,636 |
Arlington Group Asset Management Limited (1) | 1,818,181 |
Maree Wilms | 363,636 |
(1) Arlington Group Asset Management Limited, an entity in which Charlie Cannon-Brookes, Executive Director, has a 50 per cent. interest.
The participation of the Subscribing Directors each constitutes related party transactions under Rule 13 of the AIM Rules.
Accordingly, Matthew Wrigley as independent director, having consulted with the Company's Nominated Adviser, Cavendish Capital Markets Limited, considers that the terms of the participation in the Fundraising by the Subscribing Directors are fair and reasonable insofar as the Company's Shareholders are concerned.
Extraordinary General Meeting
The Fundraising and the issue of the New Shares are conditional upon, among other things, the Resolution being duly passed by Shareholders at the Extraordinary General Meeting.
The Circular, containing further details of the Fundraising and notice of the General Meeting to be held on or around 11.00 a.m. on 3 December 2024 to, inter alia, approve the resolution required to implement the Fundraising, is expected to be published and despatched to Shareholders on or around 15 November 2024. Following its publication, the Shareholder Circular will be available on the Group's website www.dukecapital.com/investors-info/.
Admission, Settlement and Dealings
Application will be made to the London Stock Exchange for admission of the New Shares to trading on AIM, being the market of that name operated by the London Stock Exchange.
It is expected that admission of the New Shares will take place on or around 8.00 a.m. on 4 December 2024 and that dealings in the New Shares on AIM will commence at the same time.
In addition to the passing of the Resolution at the General Meeting, the Placing, Broker Option and Subscription, are conditional upon, inter alia, Admission becoming effective. The Placing and Broker Option is not subject to clawback under the Retail Offer.
A further announcement will be made in relation to total voting rights in the Company's share capital following the announcement of the results in respect of the Broker Option, Retail Offer and accordingly the final number of New Shares to be issued pursuant to the Fundraising.
Capitalised terms used in this announcement (this "Announcement") have the meanings given to them in the Company's announcement dated 14 November 2024 released at 5:02pm, unless the context provides otherwise.
This announcement should be read in conjunction with the full text of the Circular to be posted to Shareholders on or around15 October 2024, a copy of which shall be available on the Company's website at www.dukecapital.com/investors-info/.
***ENDS***
For further information, please visit https://dukecapital.com/ or contact:
Duke Capital Limited | Neil Johnson / Charles Cannon Brookes / Hugo Evans
| +44 (0) 1481 231 816 |
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) | Stephen Keys / Callum Davidson / Michael Johnson | +44 (0) 207 220 0500
|
Canaccord Genuity Limited (Joint Broker)
| Adam James / Harry Rees | +44 (0) 207 523 8000 |
SEC Newgate (Financial Communications) | Elisabeth Cowell / Alice Cho / Matthew Elliott | + +44 (0) 20 3757 6882 [email protected] |
About Duke Capital
Duke is a leading provider of hybrid capital solutions for SME business owners in Europe and North America, combining the best features of both equity and debt.
Since 2017, Duke has provided unique long-term financing which eliminates re-financing risk and necessity for a short-term exit by providing a unique 'corporate mortgage' while also aligning its returns to grow with the success of the business.
Duke is focused on generating attractive risk-adjusted returns for shareholders and has a track record of achieving this across market cycles. It's three investment pillars are capital preservation, attractive dividend yield, and to provide upside upon exits. Duke is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.